Evidence map›Paper›PMID 31822681›Full record

ArticleNPJ primary care respiratory medicine2019

Gender differences among Swedish COPD patients: results from the ARCTIC, a real-world retrospective cohort study.

Karin Lisspers, Kjell Larsson, Christer Janson, Björn Ställberg, Ioanna Tsiligianni, Florian S Gutzwiller, Karen Mezzi, Bine Kjoeller Bjerregaard, Leif Jorgensen, Gunnar Johansson

Open access · goldAbstract readMulticenter Study
In one paragraph

Article in NPJ primary care respiratory medicine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed, 3 pooled it
5.4field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 3 syntheses or guidelines pooled it, 67 citations in OpenAlex.

  1. Pooled it
  2. Equity in pulmonary rehabilitation delivery: a systematic review and meta-analysis.European respiratory review : an official journal of the European Respiratory Society · 2025
    Pooled it
  3. Pooled it
  4. Article
  5. Review
  6. Article
  7. Sex Differences and Survival Among COPD Patients in France: The Palomb Cohort.International journal of chronic obstructive pulmonary disease · 2026
    Observational
  8. Article
  9. Article
  10. Review
  11. The Burden of COPD with Type 2 Inflammation in North-West Continental Europe.International journal of chronic obstructive pulmonary disease · 2025
    Review
  12. Article
  13. Article
  14. COPD in Never-Smokers: BOLD Australia Study.International journal of chronic obstructive pulmonary disease · 2024
    Article
  15. Article
  16. Article
  17. The Role of Early Warning Scoring Systems NEWS and MEWS in the Acute Exacerbation of COPD.Clinical medicine insights. Circulatory, respiratory and pulmonary medicine · 2023
    Article
  18. Factors Associated with the Non-Exacerbator Phenotype of Chronic Obstructive Pulmonary Disease.International journal of chronic obstructive pulmonary disease · 2023
    Article
  19. Understanding Sex-based Differences in Intensive Care Unit Mortality: Moving Beyond the Biology.American journal of respiratory and critical care medicine · 2022
    Article
  20. Sex Differences in Mortality of ICU Patients According to Diagnosis-related Sex Balance.American journal of respiratory and critical care medicine · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 3 countries.

Karin LisspersDepartment of Public Health and Caring Sciences, Family Medicine and Preventive Medicine, Uppsala University, Uppsala, Sweden. karin.lisspers@ltdalarna.se.
Kjell LarssonDepartment of Pulmonary Medicine, Work Environment Toxicology, Karolinska Institutet, Stockholm, Sweden.
Christer JansonDepartment of Medical Sciences: Respiratory, Allergy and Sleep Research, Uppsala University, Uppsala, Sweden.
Björn StällbergDepartment of Public Health and Caring Sciences, Family Medicine and Preventive Medicine, Uppsala University, Uppsala, Sweden.
Ioanna TsiligianniDepartment of Social Medicine, Health Planning Unit, Faculty of Medicine, University of Crete, Crete, Greece.
Florian S GutzwillerNovartis Pharma AG, Basel, Switzerland.ORCID http://orcid.org/0000-0001-7754-5744
Karen MezziNovartis Pharma AG, Basel, Switzerland.
Bine Kjoeller BjerregaardIQVIA Solutions, Copenhagen, Denmark.ORCID http://orcid.org/0000-0002-5233-5481
Leif JorgensenIQVIA Solutions, Copenhagen, Denmark.
Gunnar JohanssonDepartment of Public Health and Caring Sciences, Family Medicine and Preventive Medicine, Uppsala University, Uppsala, Sweden.
Uppsala University · SENovartis (Switzerland) · CHKarolinska Institutet · SEUniversity of Crete · GR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The present study aimed to generate real-world evidence regarding gender differences among chronic obstructive pulmonary disease (COPD) patients, especially as regards the diagnosis and outcomes in order to identify areas for improvement and management and optimize the associated healthcare resource allocation. ARCTIC is a large, real-world, retrospective cohort study conducted in Swedish COPD patients and a matched reference population from 52 primary care centers in 2000-2014. The incidence of COPD, prevalence of asthma and other comorbidities, risk of exacerbations, mortality rate, COPD drug prescriptions, and healthcare resource utilization were analyzed. In total, 17,479 patients with COPD were included in the study. During the study period, COPD was more frequent among women (53.8%) and women with COPD experienced more exacerbations vs. men (6.66 vs. 4.66). However, the overall mortality rate was higher in men compared with women (45% vs. 38%), but no difference for mortality due to COPD was seen between genders over the study period. Women seemed to have a greater susceptibility to asthma, fractures, osteoporosis, rheumatoid arthritis, rhinitis, depression, and anxiety, but appeared less likely to have diabetes, kidney diseases, and cardiovascular diseases. Furthermore, women had a greater risk of COPD-related hospitalization and were likely to receive a significantly higher number of COPD drug prescriptions compared with men. These results support the need to reduce disease burden among women with COPD and highlight the role of healthcare professionals in primary care who should consider all these parameters in order to properly diagnose and treat women with COPD.

Indexed as

ForecastingAgedDrug Administration RoutesFemaleFollow-Up StudiesGlucocorticoidsHumansIncidenceMaleMiddle AgedPrognosisPulmonary Disease, Chronic ObstructiveRetrospective StudiesSex DistributionSex FactorsSurvival RateGlucocorticoids

Identifiers

PMID31822681
PMCPMC6904454
OpenAlexW2994791384

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.